DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Acutaas Chemicals Limited (ACUTAAS) share price today?

Acutaas Chemicals Limited (ACUTAAS) is trading at ₹3,207.8 on the NSE, up 2.40% on the day. Source: DocStoX.

What is the PE ratio of Acutaas Chemicals Limited?

Acutaas Chemicals Limited has a price-to-earnings (PE) ratio of 73.7 in the Healthcare sector.

What is the market capitalisation of Acutaas Chemicals Limited?

Acutaas Chemicals Limited has a market capitalisation of approximately ₹26,248 crore.

Is Acutaas Chemicals Limited a profitable company?

Acutaas Chemicals Limited generates a return on equity of 21.5% with a net profit margin of 26.6%. That is a strong return on shareholder capital.

What is the 52-week high and low of ACUTAAS?

Acutaas Chemicals Limited (ACUTAAS) has traded between ₹1,528 and ₹3,740 over the past 52 weeks, against a current price of ₹3,207.8.

Does Acutaas Chemicals Limited pay a dividend?

Yes. Acutaas Chemicals Limited currently offers a dividend yield of 0.07%. Dividend payments depend on the board's declaration each year.

Acutaas Chemicals Limited

₹3,207.80▲ +75.30 (+2.40%)

ACUTAAS·NSE·Healthcare

Market Cap

26247.88 Cr

PE Ratio

73.73

Volume

4,57,294

Day High - Low

3219.00 - 3116.60

52W High-Low

3740.00 - 1528.00

₹3,207.80▲ +75.30 (+2.40%)

Market Cap26247.88 Cr

PE Ratio73.73

Volume4,57,294

Day High - Low3219.00 - 3116.60

52W High-Low3740.00 - 1528.00

Acutaas Chemicals Limited (ACUTAAS): company summary

The company's business is improving, with annual revenue rising 33.0% and annual net profit jumping 122.7%.

Acutaas Chemicals Limited (ACUTAAS) is a mid-cap Healthcare company valued at ₹26,248 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Acutaas Chemicals Limited last traded at ₹3,207.8, up 2.40% on the day.
Recent developments: On 2026-08-18, Acutaas Chemicals received ECMS approval for its electrolyte-additives manufacturing business, which supports its expansion into domestic electronics components.
Financial performance: The company's business is improving, with annual revenue rising 33.0% and annual net profit jumping 122.7%. The latest quarter saw revenue rise 59.3% and net profit grow 70.4% compared to the same quarter a year earlier. Net profit margin widened 10.7 percentage points to 26.6%, while return on equity and return on capital employed remain strong at 21.5% and 28.8%, respectively.
Valuation multiples: The stock trades at 73.7 times earnings, a premium to the Healthcare median of 32.0, 17.09 times book value. It yields 0.1%.
Things to watch: The stock is 15.5% below its 52-week high, and promoter holding remains at 32.66% as of 2026-06-30.
Where it stands: The company has delivered strong revenue and profit growth, with the latest quarter showing significant gains. The stock is 15.5% below its 52-week high.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

6.9/10

Fair

Fair Value

ROE

21.54%

Strong

P/E

73.73x

Expensive

Debt / Equity

0.02

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250

Day₹3117

₹3219

52W₹1528

₹3740

DocStoX take

Supported by growth (10.0) and quality (8.7), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

6.9

/10

Fair

Quality

Excellent

ROE 21.5%

Valuation

Expensive

P/E 73.7×

Growth

Strong

Revenue +31.5% 5Y CAGR

Risk

Low risk

D/E 0.02

Momentum

Strong

76% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹3,208

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹26,248 Cr

52W High / Low

₹3740 / ₹1528

Dividend Yield

0.07%

Promoter Holding

32.66%

EPS (TTM)

₹43.51

Book Value

₹201.97

Key highlights

Profit compounding 46% a year
Revenue compounding 31% a year
Low leverage — D/E 0.02
Valuation is weak (0.0/10)
Expensive at 74× earnings

4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore ACUTAAS CHEMICALS LIMITED’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

ACUTAAS CHEMICALS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare ACUTAAS CHEMICALS LIMITED with peers

ACUTAAS CHEMICALS LIMITED vs Sun Pharmaceutical Industries Limited ACUTAAS CHEMICALS LIMITED vs Divi's Laboratories Limited ACUTAAS CHEMICALS LIMITED vs Torrent Pharmaceuticals Limited ACUTAAS CHEMICALS LIMITED vs Apollo Hospitals Enterprise Limited ACUTAAS CHEMICALS LIMITED vs Zydus Lifesciences Limited ACUTAAS CHEMICALS LIMITED vs Laurus Labs Limited

Related tools & concepts

Value ACUTAAS CHEMICALS LIMITED with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

ACUTAAS newsLatest coverage & filings Open screenerFilter the whole market